Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

Completed · Not applicable

Conditions studied: Medication Adherence, Kidney Transplantation

In brief

Medication non-adherence is a major problem in kidney transplant recipients; young people 12-24 years of age are at particularly high risk for non-adherence and graft failure compared to young children and adults. Given that poor medication contributes greatly to graft failure, clinically feasible and effective interventions are urgently needed to improve adherence, survival, and quality of life in this population. The broad aim of this prospective, 3-stage, sequential study is to improve medication adherence in adolescent kidney transplant recipients by: 1) adapting the successful Teen Adherence in Kidney transplant Effectiveness of Intervention Trial (TAKE-IT) intervention for use in 'real world' clinical care, 2) designing and testing a new portable electronic pillbox and companion tracking website interface, and 3) preliminary testing of the adapted intervention.

Key facts

Study ID
NCT04288271
Run by
McGill University Health Centre/Research Institute of the McGill University Health Centre
People needed
96
Starts
2022-02-04
Expected to finish
2023-06-30
Last updated by the study team
2024-03-15

Who can join

Age: 12 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.